Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Aude Lamy"'
Autor:
Gwenaëlle Arhant, MD, Samy Lachkar, MD, Pierre-Alain Thiebaut, MD, PhD, Florent Marguet, MD, PhD, Aude Lamy, PhD, Luc Thiberville, MD, PhD, Mathieu Salaün, MD, PhD, Florian Guisier, MD, PhD, Jean-Christophe Sabourin, MD, PhD, Nicolas Piton, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 2, Pp 100596- (2024)
Introduction: DNA genotyping from plasma is a useful tool for molecular characterization of NSCLC. Nevertheless, the false-negative rate justifies the development of methods with higher sensitivity, especially in difficult-to-reach peripheral lung tu
Externí odkaz:
https://doaj.org/article/263e9bffb515469986866343ca6fcee5
Autor:
Emna Haddad, MD, Benjamin Bottet, MD, Pierre-Alain Thiebaut, MD, PhD, Samira Morin, MD, Hélène Dreyfus, MD, Élise Vannier, MD, Colette Vincent, MD, Florent Marguet, MD, PhD, Aude Lamy, PhD, Hagay Sobol, MD, PhD, Jean-Marc Baste, MD, PhD, Florian Guisier, MD, PhD, Jean-Christophe Sabourin, MD, PhD, Nicolas Piton, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 1, Pp 100595- (2024)
Lynch syndrome is the most common autosomal dominant inherited cancer predisposing syndrome, due to mutations in DNA mismatch repair genes. The key feature of cancers in Lynch syndrome is microsatellite instability and a high risk of developing mainl
Externí odkaz:
https://doaj.org/article/6f1a4664bb8e429f9e29157c3934705a
Publikováno v:
Diagnostic Pathology, Vol 16, Iss 1, Pp 1-9 (2021)
Abstract Background Pseudomyxoma peritonei (PMP) is a complex and partially understood disease defined by mucin deposits in the peritoneal cavity, mostly of appendiceal origin caused by the rupture of a mucocele often containing Low or High grade App
Externí odkaz:
https://doaj.org/article/c8c9e253832448bd9bcf9922ff5a4d6c
Autor:
Cleo Keppens, Elisabeth M. C. Dequeker, Etienne Rouleau, Nils ’t Hart, Lukas Bubendorf, Kelly Dufraing, Céline Garrec, Paul Guéguen, Aude Lamy, Antonio Marchetti, Patrick Pauwels, Ales Ryska, Véronique Tack, Luigi Tornillo, Kaat Van Casteren, Jan H. von der Thüsen, Karen Zwaenepoel, Birgit Lissenberg-Witte, Erik Thunnissen, Ed Schuuring
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Correct identification of the EGFR c.2369C>T p.(Thr790Met) variant is key to decide on a targeted therapeutic strategy for patients with acquired EGFR TKI resistance in non-small cell lung cancer. The aim of this study was to eval
Externí odkaz:
https://doaj.org/article/a6a32d9ed52f4d1a8db1c8899b5c04ee
Publikováno v:
Gastroenterology Research and Practice, Vol 2015 (2015)
KRAS genotyping is mandatory in metastatic colorectal cancer treatment prior to undertaking antiepidermal growth factor receptor (EGFR) monoclonal antibody therapy. BRAF V600E mutation is often present in colorectal carcinoma with CpG island methylat
Externí odkaz:
https://doaj.org/article/bdd539b56da74a7f9a9ba07d42bc7213
Autor:
Nicolas Piton, Marie-Delphine Lanic, Florent Marguet, Aude Lamy, France Blanchard, Florian Guisier, Mathieu Viennot, Mathieu Salaün, Luc Thiberville, Fabrice Jardin, Jean-Christophe Sabourin, Philippe Ruminy
Publikováno v:
Laboratory Investigation
Laboratory Investigation, Nature Publishing Group, 2021, 101 (5), pp.648-660. ⟨10.1038/s41374-021-00536-2⟩
Laboratory Investigation, Nature Publishing Group, 2021, 101 (5), pp.648-660. ⟨10.1038/s41374-021-00536-2⟩
International audience; Theranostic translocations may be difficult to detect by routine techniques, especially when specimens are exiguous. We recently demonstrated in a series of translocated lung adenocarcinomas that LD-RT-PCR (ligation-dependent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db920454d1b21fa1b16dd002184dd904
https://hal.archives-ouvertes.fr/hal-03226491
https://hal.archives-ouvertes.fr/hal-03226491
Publikováno v:
Annales de pathologie. 41(5)
High throughput RNA sequencing, also know as RNAseq, can easily be performed on the gold-standard technique of formalin-fixed paraffin-embedded tissue, which has long been successfully used in routine practice by pathologists. For this reason, RNAseq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::054064b7535fbbf7b913c326e8222504
https://pubmed.ncbi.nlm.nih.gov/34376297
https://pubmed.ncbi.nlm.nih.gov/34376297
Autor:
Kaat Van Casteren, Karen Zwaenepoel, Aude Lamy, Elisabeth Dequeker, Nils A. 't Hart, Céline Garrec, Jan H. von der Thüsen, Paul Guéguen, Cleo Keppens, Luigi Tornillo, Véronique Tack, Lukas Bubendorf, Patrick Pauwels, Etienne Rouleau, Ed Schuuring, Birgit I. Lissenberg-Witte, Kelly Dufraing, Erik Thunnissen, Antonio Marchetti, Ales Ryska
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
BMC Cancer
BMC cancer
Keppens, C, Dequeker, E M C, Rouleau, E, T'Hart, N, Bubendorf, L, Dufraing, K, Garrec, C, Guéguen, P, Lamy, A, Marchetti, A, Pauwels, P, Ryska, A, Tack, V, Tornillo, L, Van Casteren, K, Von Der Thüsen, J H, Zwaenepoel, K, Lissenberg-Witte, B, Thunnissen, E & Schuuring, E 2020, ' Sensitive detection methods are key to identify secondary EGFR c.2369C >T p.(Thr790Met) in non-small cell lung cancer tissue samples ', BMC Cancer, vol. 20, no. 1, 366 . https://doi.org/10.1186/s12885-020-06831-3
BMC Cancer, 20(1):366. BioMed Central Ltd.
BMC Cancer, 20(1):366. BMC
BMC Cancer, 20(1):366. BioMed Central
BMC Cancer
BMC cancer
Keppens, C, Dequeker, E M C, Rouleau, E, T'Hart, N, Bubendorf, L, Dufraing, K, Garrec, C, Guéguen, P, Lamy, A, Marchetti, A, Pauwels, P, Ryska, A, Tack, V, Tornillo, L, Van Casteren, K, Von Der Thüsen, J H, Zwaenepoel, K, Lissenberg-Witte, B, Thunnissen, E & Schuuring, E 2020, ' Sensitive detection methods are key to identify secondary EGFR c.2369C >T p.(Thr790Met) in non-small cell lung cancer tissue samples ', BMC Cancer, vol. 20, no. 1, 366 . https://doi.org/10.1186/s12885-020-06831-3
BMC Cancer, 20(1):366. BioMed Central Ltd.
BMC Cancer, 20(1):366. BMC
BMC Cancer, 20(1):366. BioMed Central
Background Correct identification of the EGFR c.2369C>T p.(Thr790Met) variant is key to decide on a targeted therapeutic strategy for patients with acquired EGFR TKI resistance in non-small cell lung cancer. The aim of this study was to evaluate the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4978998aad12fe2a0b25bdb6f55aa8d
https://doi.org/10.1186/s12885-020-06831-3
https://doi.org/10.1186/s12885-020-06831-3
Autor:
Radu Pirlog, Nicolas Piton, Aude Lamy, Florian Guisier, Ioana Berindan-Neagoe, Jean-Christophe Sabourin, Florent Marguet
Publikováno v:
Cancers; Volume 14; Issue 4; Pages: 1030
Lung adenocarcinoma (LUAD) is the major subtype of non-small cell lung cancer, accounting for approximately 60% of cases. Molecular analysis of LUADs showed that the KRAS gene is mutated in up to 30% of cases; such cases were previously considered
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a34f2938a60f00fc34d69113dd32b0b8
https://doi.org/10.3390/cancers14041030
https://doi.org/10.3390/cancers14041030
Autor:
Samy Lachkar, Luc Thiberville, Aude Lamy, Bérengère Obstoy, Florian Guisier, Mathieu Salaün, Nicolas Piton, Jean-Christophe Sabourin
Publikováno v:
Respirology. 21:718-726
Background and objective Treatment optimization of non-squamous non-small-cell lung cancers (nonSq-NSCLC) relies on the molecular analysis of the tumour. We aimed to assess the predictive factors of molecular analysis feasibility (MAF) from samples o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f02641b63171e49b376030846f6acff
https://doi.org/10.1111/resp.12737
https://doi.org/10.1111/resp.12737